Global Blood Viscometer Market is segmented By Product Type (Rotational viscometer, Capillary viscometer, Others) By End-User (Hospitals & Clinics, Diagnostic laboratories, Others) and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) – Share, Size, Outlook, and Opportunity Analysis, 2024-2031
Blood Viscometer Market Overview
The global blood viscometers market reached US$ 1.73 billion in 2023 and is expected to reach US$ 2.5 billion by 2031, growing at a CAGR of 4.7% during the forecast period 2024-2031.
Blood gas monitoring devices are utilized to measure the blood's pH, carbon dioxide (CO2), and oxygen (O2). The diagnosis and treatment of numerous illnesses, including heart disease, metabolic abnormalities, and respiratory issues, depend on this knowledge. Blood gas levels are measured using point-of-care blood gas monitors and blood gas analyzers.
Devices for measuring blood gas are vital for both controlling and diagnosing a wide range of illnesses. They can assist in making sure patients get the care they require to become better. It aids in the diagnosis of ailments like as asthma, chronic obstructive pulmonary disease (COPD), pneumonia, and more. Blood gas monitoring can be crucial in evaluating heart failure, a condition where the heart struggles to pump blood effectively.
Blood Viscometer Market Scope
| Metrics | Details |
| CAGR | 4.7% |
| Market Size Available for Years | 2023-2031 |
| Estimation Forecast Period | 2024-2031 |
| Revenue Units | Value (US$ Mn) |
| Segments Covered | Product Type, End User |
| Regions Covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Largest Region | North America |
| Fastest Growing Region | Asia-Pacific |
| Report Insights Covered | Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter’s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights. |
For more details on this report – Request for Sample
Blood Viscometer Market Dynamics: Drivers & Restraints
Increasing prevalence of vascular diseases
The increasing prevalence of vascular diseases is expected to drive the market growth. Blood viscometers help in identifying patients at risk for developing vascular diseases high blood viscosity can be an indicator of increased risk for blood clots, which can lead to vascular events like strokes and heart attacks.
For instance, according to the report published by the World Health Organization in 2021, it is estimated that about 17.9 million lives are being taken by cardiovascular diseases. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease and other conditions.
Additionally, according to a report published by the American Lung Association in 2023, it is estimated that pulmonary embolism affects around 900,000 people in the U.S. every year. In most cases, pulmonary embolism is caused by blood clots in the legs, called deep vein thrombosis, that travel to the lungs. Blood viscometer helps in monitoring patients with vascular diseases including pulmonary embolism. Thus, the above factors are expected to drive the market growth during the forecast period.
High cost of blood viscometers
High cost of the blood viscometers is expected to hinder the market growth. Hospitals and clinics, especially in developing countries, often have tight budgets for medical equipment. The high cost of blood viscometers makes them less accessible apart from their advantages. The alternative options are preferred over blood viscometers by reducing their demand. Thus, the above factors are expected to hinder the market growth.
Blood Viscometer Market Segment Analysis
The global blood viscometer market is segmented based on product type, end-user and region.
Rotational viscometer segment is expected to dominate the market growth
Rotational viscometers segment is expected to hold a dominant position in the market share. This is due to the advantages of the viscometers over the other types of viscometers. Compared to certain other devices and procedures, rotational viscometers can handle a larger range of blood viscosities. They can therefore be used to analyze blood from both healthy donors and donors who have abnormal blood viscosity.
The possibility of human mistakes during measurement is decreased by the automation seen in many modern rotational viscometers. Rotational blood viscometers find application in various areas of healthcare and research due to their ability to measure blood viscosity accurately and across different shear rates. Rotational blood viscometers can assess blood viscosity in patients suspected of having conditions that affect blood flow. Thus, the above factors are expected to hold the segment in the market share.
Blood Viscometer Market Geographical Analysis
North America is expected to hold a significant position in blood viscometer market share
North America is expected to hold a dominant position in the market share. This is due to the presence of several major players in the region, the increasing prevalence of vascular and kidney diseases in the region and also the improved healthcare infrastructure.
Diabetes mellitus, especially uncontrolled diabetes, can lead to several changes in the composition and flow characteristics of blood. These changes contribute to increased blood viscosity. For instance, the American Diabetes Association in 2021 stated that almost 38.4 million Americans which is almost 11.6% of the population, had diabetes. 2 million Americans have type 1 diabetes, including about 304,000 children and adolescents.
COVID-19 Impact Analysis On Blood Viscometer Market
COVID-19 has a positive impact on the market growth. The market was stimulated by the increased need for blood gas monitoring equipment in clinics and hospitals. Point-of-care blood gas monitors have grown in value because of their portability and speedy results delivery, which help COVID-19 patients make timely treatment decisions. However, lockdowns and travel restrictions caused delays in the production and delivery of medical supplies, notably blood gas monitors, which resulted in a shortage of equipment in some areas. Thus, the pandemic has a moderate impact on the market.
Blood Viscometer Market Competitive Landscape
The major global players in the market include RheoSense, Inc., Benson Viscometers Ltd, BioFluid Technology, Inc., Anton Paar GmbH, Health Onvector, PCE Instruments UK Ltd., KYOTO ELECTRONICS MANUFACTURING CO., LTD., A&D Company, Limited, AMETEK Brookfield Inc., and Microsilindia among others.
Why Purchase the Report?
- To visualize the global blood viscometer market segmentation based on product type, end-user and region as well as understand key commercial assets and players.
- Identify commercial opportunities by analyzing trends and co-development.
- Excel data sheet with numerous data points of blood viscometer market-level with all segments.
- PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
- Product mapping available as excel consisting of key products of all the major players.
The global blood viscometer market report would provide approximately 53 tables, 47 figures and 176 pages.
Target Audience 2024
- Manufacturers/ Buyers
- Industry Investors/Investment Bankers
- Research Professionals
- Emerging Companies
